Dear Doctor - Participate in the Survey on hepatitis of unknown etiology " A recent survey of hepatitis cases of unknown etiology in children found that the vast majority of cases were in infants under the age of 6 months. The most common symptoms reported were fever, diarrhea, and vomiting. However, a small number of children also had jaundice and liver enzymes that were elevated. The most common tests used to diagnose hepatitis are the alanine aminotransferase (ALT) test and the aspartate aminotransferase (AST) test. These tests can be used to identify liver damage and determine the cause of the hepatitis. In some cases, additional testing, such as a viral load test or a liver biopsy, may be needed to confirm the diagnosis. Treatment for hepatitis usually involves supportive care, such as rest and fluids, and may also include medications to reduce liver inflammation or suppress the immune system. Participate in Surveys "
1.
New policy review highlights the importance of health-related quality of life in advanced cancer
2.
New protocols, according to a study, allow many patients to safely return home one day after lung cancer surgery.
3.
Study identifies new target for obesity-related breast cancer
4.
Novel Agent Effective for Cancer Wasting Disorder
5.
The response of bipolar patients to lithium may be predicted by ancestry.
1.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
2.
Targeted Approaches to Breast Cancer Liver Metastases: Surgery, Ablation, and Survival Insights
3.
Integrated Updates in Oncology for Specialists
4.
Pediatric Advances in Mapping Hematopoietic Development During Childhood
5.
The Importance of Balanced Potassium Levels in Maintaining Good Health
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Rates of CR/CRi and MRD Negativity in Iontuzumab-Treated Patients
2.
CDK4/6 Inhibitors Redefining Treatment for HR+/HER2- aBC In Post-Menopausal Women- A Panel Discussion
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part I
4.
Current Scenario of Cancer- An Overview of The Incidence of Cancer in Men
5.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation